Drug
Stelara
Stelara: highest development phase Phase 3, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Stelara NCT05335356 | Phase 3 | Moderate to Severe Chronic Plaque Psoriasis |
Latest
No recent events.
Follow Stelara on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.